Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression.

Avasarala S, Van Scoyk M, Wang J, Sechler M, Vandervest K, Brzezinski C, Weekes C, Edwards MG, Arcaroli J, Davis RE, Bikkavilli RK, Winn RA.

Biol Open. 2013 May 22;2(7):675-85. doi: 10.1242/bio.20134507. Print 2013 Jul 15.

2.

Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.

Avasarala S, Bikkavilli RK, Van Scoyk M, Zhang W, Lapite A, Hostetter L, Byers JT, Heasley LE, Sohn JW, Winn RA.

PLoS One. 2013 Oct 18;8(10):e76895. doi: 10.1371/journal.pone.0076895. eCollection 2013.

3.

Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA.

Mol Cancer Res. 2010 Jun;8(6):833-43. doi: 10.1158/1541-7786.MCR-09-0400. Epub 2010 May 25.

4.

WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.

Yoshioka S, King ML, Ran S, Okuda H, MacLean JA 2nd, McAsey ME, Sugino N, Brard L, Watabe K, Hayashi K.

Mol Cancer Res. 2012 Mar;10(3):469-82. doi: 10.1158/1541-7786.MCR-11-0177. Epub 2012 Jan 9.

5.

Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer.

Bikkavilli RK, Avasarala S, Van Scoyk M, Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T, Tauler J, Borowicz S, Lussier YA, Parr BA, Cool CD, Winn RA.

Oncogene. 2015 Oct 16;34(42):5317-28. doi: 10.1038/onc.2015.2. Epub 2015 Mar 2. Erratum in: Oncogene. 2015 Oct 16;34(42):5406.

6.

Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.

Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, Hammond M, Van Scoyk M, Acosta H, Mirus J, Barry N, Bren-Mattison Y, Van Raay TJ, Nemenoff RA, Heasley LE.

J Biol Chem. 2005 May 20;280(20):19625-34. Epub 2005 Feb 10.

7.

Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer.

Bravo DT, Yang YL, Kuchenbecker K, Hung MS, Xu Z, Jablons DM, You L.

BMC Cancer. 2013 Jul 1;13:316. doi: 10.1186/1471-2407-13-316.

8.

Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p.

Huang X, Zhu H, Gao Z, Li J, Zhuang J, Dong Y, Shen B, Li M, Zhou H, Guo H, Huang R, Yan J.

J Biol Chem. 2018 May 4;293(18):6693-6706. doi: 10.1074/jbc.RA118.001689. Epub 2018 Mar 16.

PMID:
29549123
9.

Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.

Carmon KS, Loose DS.

Mol Cancer Res. 2008 Jun;6(6):1017-28. doi: 10.1158/1541-7786.MCR-08-0039.

10.

Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer.

Tennis MA, Vanscoyk MM, Wilson LA, Kelley N, Winn RA.

PLoS One. 2012;7(3):e32921. doi: 10.1371/journal.pone.0032921. Epub 2012 Mar 5.

11.

Redundant expression of canonical Wnt ligands in human breast cancer cell lines.

Benhaj K, Akcali KC, Ozturk M.

Oncol Rep. 2006 Mar;15(3):701-7.

PMID:
16465433
12.

WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.

King ML, Lindberg ME, Stodden GR, Okuda H, Ebers SD, Johnson A, Montag A, Lengyel E, MacLean Ii JA, Hayashi K.

Oncogene. 2015 Jun;34(26):3452-62. doi: 10.1038/onc.2014.277. Epub 2014 Sep 1.

13.

SRF-miR‑29b-MMP2 axis inhibits NSCLC invasion and metastasis.

Wang HY, Tu YS, Long J, Zhang HQ, Qi CL, Xie XB, Li SH, Zhang YJ.

Int J Oncol. 2015 Aug;47(2):641-9. doi: 10.3892/ijo.2015.3034. Epub 2015 Jun 5.

PMID:
26044095
14.

Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.

Miao Y, Wang L, Zhang X, Xu X, Jiang G, Fan C, Liu Y, Lin X, Yu J, Zhang Y, Wang E.

PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014.

15.

Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.

Yang L, Chen Y, Cui T, Knösel T, Zhang Q, Albring KF, Huber O, Petersen I.

Carcinogenesis. 2012 Oct;33(10):1863-70. doi: 10.1093/carcin/bgs226. Epub 2012 Jul 12.

PMID:
22791817
16.

Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.

Othman N, In LL, Harikrishna JA, Hasima N.

PLoS One. 2013 Dec 10;8(12):e81735. doi: 10.1371/journal.pone.0081735. eCollection 2013.

17.

Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer.

Liu W, Yi DD, Guo JL, Xiang ZX, Deng LF, He L.

J Ethnopharmacol. 2015 May 13;165:83-93. doi: 10.1016/j.jep.2015.02.015. Epub 2015 Feb 16.

PMID:
25698245
18.
19.

Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans.

Kim TH, Moon JY, Kim SH, Paik SS, Yoon HJ, Shin DH, Park SS, Sohn JW.

J Korean Med Sci. 2015 Feb;30(2):155-61. doi: 10.3346/jkms.2015.30.2.155. Epub 2015 Jan 21.

20.

WNT7a induces E-cadherin in lung cancer cells.

Ohira T, Gemmill RM, Ferguson K, Kusy S, Roche J, Brambilla E, Zeng C, Baron A, Bemis L, Erickson P, Wilder E, Rustgi A, Kitajewski J, Gabrielson E, Bremnes R, Franklin W, Drabkin HA.

Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10429-34. Epub 2003 Aug 22.

Supplemental Content

Support Center